Clicky

HylaPharm

HylaPharm HylaPharm is a Kansas University spinout company developing cancer chemotherapies targeted for potentially deadly, locally advanced cancers.

"It worked like a charm for Remy. The dog was cancer-free after one treatment. 'It's really exciting to be part of that,...
06/19/2018
New treatment from KU Cancer Center, successful in dogs, could eliminate need for chemotherapy

"It worked like a charm for Remy. The dog was cancer-free after one treatment. 'It's really exciting to be part of that, to think that her results and her reaction and everything with her is eventually to be used in humans. It's a wonderful thing,' Yoder said with pride."
-41 Action News - KSHB-TV

If your dog has recently been diagnosed with cancer, HylaPharm has a drug in clinical trials that might be able to help.
Contact Jerome Adams at: [email protected] or call 913-213-3028 for more information if you think your dog could be a candidate.

Doctors are testing a new cancer treatment developed by University of Kansas Cancer Center on dogs. Early successes show it may eliminate the need for chemotherapy in certain cases for humans. 

10/27/2017

Science has the power to change the world, and I enjoyed talking today about the importance of scientific research with The Science Coalition and founders of companies created from federally-funded research, including HylaPharm President Andrew Hansen from Lawrence.

We must encourage the next generation to study STEM education to continue making progress in these fields. My Senate Competitiveness Caucus co-chair U.S. Senator Chris C***s and I continue to work with our colleagues to make certain there are science-related jobs waiting for our students in Kansas and beyond upon their graduation to meet these goals.

10/27/2017

Each of their companies is bringing transformational innovations to the marketplace. Each of their companies began with federally funded university research. #AmericanMadeInnovation #SparkingEconomicGrowth Learn more: http://bit.ly/americanmadeinnovation

09/08/2017

Attention Dog Owners: If your dog has recently been diagnosed with cancer, there is a drug in clinical trials that might be able to help. This drug developed by Hylapharm has had success eradicating locally advanced cancer in canines. They are accepting new dogs now for the next round of trials. If you think your dog could be a candidate, contact us at [email protected] or call us at 913-213-3028.

09/26/2016

We are so so thankful for this study that Vedel is a part of. The prednisone treatment and surgeries she had gone through did not help her. Even though her tumor has not gone away it has slowed it's growth with no adverse reactions to the chemo like the prednisone was doing to her. THANK YOU for allowing us to be a part of this and giving our girl a chance at a longer more healthier life. Sincerely The Taylor Family

09/16/2016
Kansas City Clinical Dog Cancer Trial

This Kansas City clinical dog cancer trial uses a new anti-cancer drug that is injected directly into cancers. Patients are still being accepted.

If you think your dog could be a candidate, contact Jerome Adams at: [email protected] or call 913-213-3028 for more information.

Address

2029 Becker Drive, Suite 285
Lawrence, KS
66047

Telephone

(785) 371-0147

Alerts

Be the first to know and let us send you an email when HylaPharm posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos

Category

Nearby pet stores & pet services


Comments

Check out the innovative technologies HylaPharm, Deciphera Pharmaceuticals, and Cereset are developing for the health-care industry! https://btbcku.com/on-the-cutting-edge/
Was wondering what the status of your drug, Caninamide, is?